Moderate-intensity statin plus ezetimibe vs high-intensity statin according to baseline LDL-C in the treatment of atherosclerotic cardiovascular disease: A post-hoc analysis of the RACING randomized trial

Lee, Bom; Hong, Sung-Jin; Rha, Seung-Woon; Heo, Jung Ho; Hur, Seung-Ho; Choi, Hyun Hee; Kim, Kyung-Jin; Kim, Ju Han; Kim, Hyun Kuk; Kim, Ung; Choi, Yu Jeong; Lee, Yong-Joon; Lee, Seung-Jun; Ahn, Chul-Min; Ko, Young-Guk; Kim, Byeong-Keuk; Choi, Donghoon; Hong, Myeong-Ki; Jang, Yangsoo; Kim, Jung-Sun

doi:10.1016/j.atherosclerosis.2023.117373

Atherosclerosis

2023

DOI: 10.1016/j.atherosclerosis.2023.117373

|View full text |Cite

Moderate-intensity statin plus ezetimibe vs high-intensity statin according to baseline LDL-C in the treatment of atherosclerotic cardiovascular disease: A post-hoc analysis of the RACING randomized trial

Bom Lee,

Sung-Jin Hong,

Seung-Woon Rha

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Evolution of LDL-C lowering medications and their cardiovascular benefits: Past, present, and future

Faluk,

Wardhere,

Mohamoud

et al. 2024

Current Problems in Cardiology

View full text Add to dashboard Cite

Evolution of LDL-C lowering medications and their cardiovascular benefits: Past, present, and future

Faluk,

Wardhere,

Mohamoud

et al. 2024

Current Problems in Cardiology

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Moderate-intensity statin plus ezetimibe vs high-intensity statin according to baseline LDL-C in the treatment of atherosclerotic cardiovascular disease: A post-hoc analysis of the RACING randomized trial

Cited by 1 publication

References 18 publications

Evolution of LDL-C lowering medications and their cardiovascular benefits: Past, present, and future

Evolution of LDL-C lowering medications and their cardiovascular benefits: Past, present, and future

Contact Info

Product

Resources

About